Lamina dura thickening in patients on antiresorptive therapy as a radiographic risk indicator of MRONJ: a retrospective longitudinal cohort study

Clicks: 16
ID: 314239
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #45 of 56 articles by views in dentomaxillofacial radiology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
AIMS: This study investigated whether antiresorptive drug (ARD) therapy is associated with lamina dura (LD) thickening, defined as a radiographic increase in the thickness of the normally thin, radiopaque cortical line surrounding the tooth root. It further evaluated whether LD thickening serves as a radiographic marker and risk indicator for medication-related osteonecrosis of the jaw (MRONJ). METHODS: Panoramic radiographs from 65 ARD-treated patients (University Hospital Leuven) and 65 age- and sex-matched controls were analysed. Inclusion criteria were prior oncological diagnosis, high-dose intravenous ARD, and radiographs before and after therapy. Three blinded oral and maxillofacial radiologists categorised LD appearance into four grades: (0) not/barely visible, (1) normal, (2) mild thickening, (3) marked thickening. Group differences and longitudinal changes were evaluated using appropriate non-parametric and time-to-event analyses. RESULTS: Among 130 participants, LD-thickness remained stable in controls but increased in ARD-treated patients (p < 0.001). Within the ARD group, LD thickening changed over time (p < 0.001): 30.6% showed no change, 55.4% developed mild thickening, and 13.8% marked thickening. Controls showed minimal change (p = 0.011), with 9.2% developing mild thickening. Kaplan-Meier analysis estimated a median time to LD thickening of 27 months, with a higher thickening probability in ARD-treated patients than controls (p < 0.001). LD thickening was not directly associated with MRONJ (p = 0.39). CONCLUSION: LD thickening is strongly associated with long-term ARD exposure and shows progressive changes. Although not directly associated with MRONJ in this cohort, it may still represent a potential risk indicator; warranting confirmation in further studies.
Reference Key
openalex_W7161786624 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sonya Radi, Samy El Bachaoui, Ilya Tsiklin, Constanza Pastenes, Hanne De Backer, Ruxandra Coropciuc, Tim Van den Wyngaert, Benoit Beuselinck, Reinhilde Jacobs
Are you one of these authors? Claim your profile
Journal dentomaxillofacial radiology
Year 2026
DOI
10.1093/dmfr/twag029
URL
https://doi.org/10.1093/dmfr/twag029
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.